Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration
Journal of Neuroinflammation · 2025
DOI: 10.1186/s12974-024-03329-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroinflammation, 2025. Verfasst von Ping-Wu Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA. pzhang5@jhmi.edu. Hauptthemen laut MEDLINE: Retinal Degeneration, Necroptosis, Ibuprofen, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
The retinal degenerative diseases retinitis pigmentosa (RP) and atrophic age- related macular degeneration (AMD) are characterized by vision loss from photoreceptor (PR) degeneration. Unfortunately, current treatments for these diseases are limited at best. Genetic and other preclinical evidence suggest a relationship between retinal degeneration and inflammation. To further explore this relationship, we tested whether Ibuprofen (IBU), an FDA-approved non-steroidal anti-inflammatory drug (NSAID), could promote PR survival and function in a mouse model of light damage (LD)-induced PR degeneration.
Methods
LD was induced by exposing mice to 4000 lx of light for 2–4 hours (h). IBU (100 or 200 mg/kg) or vehicle was administered by daily intraperitoneal injection. Retinal structure and function were evaluated by spectral-domain optical coherence tomography (SD-OCT) and electroretinography (ERG). Cell death genes were analyzed at 24 and 72 h after LD using the Mouse Pan-Cell Death Pathway PCR Array (88 genes). The cellular location and protein expression of key necroptosis genes were assessed by immunohistochemistry.
Results
Retinal outer nuclear layer (ONL) thickness in vehicle-injected LD animals was 8.7 ± 0.6% of retinas without LD ( p < 0.0001). In IBU 200 mg/kg treated mice, central ONL thickness was 74.9 ± 7.7% of untreated retinas ( p < 0.001). A-wave and b-wave ERG amplitudes were significantly preserved in IBU-treated animals. IBU significantly inhibited retinal inflammation. Twenty-four hour after LD, retinal mRNA expression for the inflammatory-factors tumor necrosis factor ( Tnf ), interleukin-1 beta ( Il1B ), and C-C motif chemokine ligand 2 ( Ccl2 ) increased by 10-, 17-, and 533-fold, respectively; in IBU-treated animals, the expression levels of these inflammatory factors were not significantly different from no-LD controls. Expression of key necroptosis genes, including Ripk3 and Mlkl , were upregulated in LD vehicle-treated mice, but dramatically reduced to near no LD levels in LD IBU-treated mice. Microglia activation and MLKL protein upregulation were observed primarily in photoreceptors 12 h after LD, as assessed by immunohistochemistry. IBU reduced the upregulation of MLKL protein and microglia migration in the ONL and outer plexiform layer (OPL) of treated retinas.
Conclusions
Systemic administration of the anti-inflammatory drug IBU partially protected mouse retinas from light-induced photochemical damage and inhibited both inflammation and the necroptosis cell death pathways. Our results suggest that NSAIDs may provide a promising therapeutic approach for treatment of the human retinal degenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA. pzhang5@jhmi.edu.
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA.
- Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA. donzack@gmail.com.
- Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA. donzack@gmail.com.
- Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA. donzack@gmail.com.
- Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21231, USA. donzack@gmail.com.
Förderung
- NEI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Zhang, P. W., Wan, Z. H., Li, W., Vats, A., Mehta, K., Fan, L., Zhou, L., Li, S., Li, G., Keuthan, C. J., Berlinicke, C., Qian, C., Esumi, N., Duh, E. J., & Zack, D. J. (2025). Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-024-03329-8
Vancouver
Zhang PW, Wan ZH, Li W, Vats A, Mehta K, Fan L, et al. Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration. Journal of Neuroinflammation. 2025. doi:10.1186/s12974-024-03329-8
BibTeX
@article{Zhang2025,
author = {Zhang, Ping-Wu and Wan, Zi-He and Li, Weifeng and Vats, Abhishek and Mehta, Kunal and Fan, Laura and Zhou, Lingli and Li, Sean and Li, Gloria and Keuthan, Casey J and Berlinicke, Cynthia and Qian, Cheng and Esumi, Noriko and Duh, Elia J and Zack, Donald J},
title = {Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration},
journal = {Journal of Neuroinflammation},
year = {2025},
doi = {10.1186/s12974-024-03329-8}
}
EUVIMED